Healthcare

Medical Developments International Limited (ASX:MVP) entered the second half of 2026 with its growth case increasingly centred on Penthrox, the company's inhaled methoxyflurane analgesic. The FY2026 result showed that pain management remained the main commercial engine, while operating cash flow and the year-end cash …

Mayne Pharma Group Limited (ASX:MYX) enters the remainder of 2026 with a different challenge from many healthcare companies: theBusinessmust now be assessed primarily on its own operating performance and strategic direction. The company remains an established specialty and generic pharmaceuticals operator with activities spanning …

EchoIQ Limited (ASX:EIQ) is a Sydney-based medical technology company developing artificial-intelligence software for cardiology. Its lead EchoSolv platform analyses echocardiogram data to help clinicians identify serious heart conditions earlier within existing care pathways. During 2026, the company progressed from regulatory and clinical milestones towards …

Tetratherix Limited (ASX:TTX) is a Sydney-based regenerative-medicine and medical-device company developing the Tetramatrix synthetic biomaterials platform. The technology is designed to be injected as a liquid before forming a soft gel-like material at body temperature and gradually resorbing. In 2026, the company’s focus has …

BLS Pharmaceuticals Limited (ASX:BLS) is an Australian pharmaceutical manufacturer focused on regulated therapeutic products, active pharmaceutical ingredients and controlled medicines. Its platform spans medicinal cannabis, psychedelic medicines and other regulated pharmaceutical products. The FY26 result marked a significant step in the company’s operating scale, …

Telix Pharmaceuticals Limited (ASX:TLX) is a Melbourne-headquartered radiopharmaceutical company developing targeted diagnostic and therapeutic products that use medical isotopes to image or treat disease. In September 2026, it agreed to acquire German isotope specialist ITM Isotope Technologies Munich, placingSupplysecurity, vertical integration and execution at …

OncoSil Medical Limited (ASX:OSL) is an Australian medical-device company focused on targeted radiation therapies for difficult-to-treat cancers. In 2026, regulatory progress widened the potential commercial reach of the OncoSil device. The next phase is therefore less about approvals alone and more about converting market …